Business Context and Reporting Period
This Form 8-K is a current report filed by Akers Biosciences, Inc. on October 19, 2018, regarding events occurring on October 18 and October 19, 2018. The company is incorporated in New Jersey and is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Departure of Officers and Directors: Richard C. Tarbox III resigned effective immediately on October 18, 2018, from his positions as interim Non-Executive Chairman, Secretary, Board member, and member of all Board committees. The resignation was voluntary due to other business commitments and not due to any disagreement with the Company.
- Committee Appointments: On October 19, 2018, Joshua Silverman was appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee to fill the vacancy left by Mr. Tarbox.
- Bylaw Amendment: The Board approved an amendment to the Amended and Restated Bylaws to authorize the election of an Executive Chairman, a Non-Executive Chairman, and a Lead Independent Director from among Board members. This change facilitates the election of a permanent Chairman.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. No specific risks or contingencies are disclosed in this report other than the standard governance transition. There are no unusual items reported.
Investor Verification Checklist
- Verify the effective date of Richard C. Tarbox III's resignation and the immediate impact on Board committee composition.
- Confirm the qualifications of Joshua Silverman for his new roles on the Audit, Compensation, and Nominating committees.
- Review the attached Exhibit 3.1 for the full text of the Bylaw amendment regarding the election of Chairman roles.
- Monitor subsequent filings for the election of a permanent Chairman as intended by the Bylaw amendment.